Showing results (551-560 of 1,593) with videos related to
Sort By:
Pageof 160
RSC Medicinal Chemistry|January 29, 2024
Latest developments in coumarin-based anticancer agents: mechanism of action and structure-activity relationship studiesManankar Koley, Jianlin Han, Vadim A Soloshonok, et al.RSC Medicinal Chemistry|January 29, 2024
Discovery of new dibenzodiazepine derivatives as antibacterials against intracellular bacteriaLing-Han Chen, Man-Yi Lin, Hsueh-Chun Lin, et al.RSC Medicinal Chemistry|July 19, 2024
Synthesis and in vitro evaluation of novel amino-phenylmethylene-imidazolone 5-HT2A receptor antagonistsGregory E DwuletRSC Medicinal Chemistry|July 19, 2024
Systematic computational strategies for identifying protein targets and lead discoveryArti Kataria, Ankit Srivastava, Desh Deepak Singh, et al.RSC Medicinal Chemistry|July 19, 2024
Design, synthesis, and structure-activity relationship studies of 6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazole derivatives as necroptosis inhibitorsZechen Jin, Yang Dai, Yinchun Ji, et al.RSC Medicinal Chemistry|July 19, 2024
Discovery of new 1,3-diphenylurea appended aryl pyridine derivatives as apoptosis inducers through c-MET and VEGFR-2 inhibition: design, synthesis, in vivo and in silico studiesHeba A Elsebaie, Mohamed S Nafie, Haytham O Tawfik, et al.RSC Medicinal Chemistry|July 19, 2024
Novel flexible biphenyl PfDHFR inhibitors with improved antimalarial activitySasithorn Decharuangsilp, Uthai Arwon, Nawarat Sooksai, et al.RSC Medicinal Chemistry|August 21, 2024
2-Aryl-1-hydroxyimidazoles possessing antiviral activity against a wide range of orthopoxviruses, including the variola virusElizaveta I Basanova, Ekaterina A Kulikova, Nikolai I Bormotov, et al.RSC Medicinal Chemistry|August 26, 2024
Discovery and evaluation of 3-(2-isocyanobenzyl)-1H-indole derivatives as potential quorum sensing inhibitors for the control of Pseudomonas aeruginosa infections in vitroJiang Wang, Jing-Yi Yang, Pradeepraj Durairaj, et al.RSC Medicinal Chemistry|August 21, 2024
Inhibiting SARS-CoV-2 viral entry by targeting spike:ACE2 interaction with O-modified quercetin derivativesReuben James Z Rosal, Monissa C PaderesPageof 160